Fabrication and characterization of poly(γ-glutamic acid)-graft-chondroitin sulfate/polycaprolactone porous scaffolds for cartilage tissue engineering

Acta Biomaterialia

Volumn 5, Issue 6, 2009, Pages 1937-1947

  Chang, Kuo Yung ^a   Cheng, Li Wei ^a   Ho, Guan Huei ^b   Huang, Yun Peng ^b   Lee, Yu Der ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b Vedan Enterprise Corporation   (Taiwan)

Author keywords

Articular cartilage; Chondroitin sulfate; Poly( glutamic acid); Poly( caprolactone)

Indexed keywords

AMINO ACIDS; BIOCOMPATIBILITY; BIODEGRADATION; BODY FLUIDS; DEGRADATION; MECHANICAL STABILITY; SCAFFOLDS (BIOLOGY); SULFUR COMPOUNDS; TISSUE REGENERATION;

ARTICULAR CARTILAGES; CARTILAGE TISSUE ENGINEERING; CHONDROCYTES; CHONDROITINSULFATE; DEGRADATION RATE; GLUTAMIC ACID; POLY(Γ-GLUTAMIC ACID); POLY(Ε CAPROLACTONE); POLY(Ε-CAPROLACTONE); WATER BINDING CAPACITY;

CARTILAGE;

1 (3 DIMETHYLAMINOPROPYL) 3 ETHYLCARBODIIMIDE; ALCIAN BLUE; BIOMATERIAL; CHONDROITIN SULFATE; GLYCOSAMINOGLYCAN; POLYCAPROLACTONE; POLYESTER; POLYGLUTAMIC ACID; TISSUE SCAFFOLD; WATER;

ANIMAL CELL; ARTICLE; ARTICULAR CARTILAGE; BINDING KINETICS; BIOCOMPATIBILITY; BIODEGRADATION; CARTILAGE CELL; CARTILAGE GRAFT; CELL FUNCTION; COMPOSITE MATERIAL; CONTROLLED STUDY; DEGRADATION KINETICS; FEMALE; HISTOCHEMISTRY; IN VITRO STUDY; LEACHING; MACROMOLECULE; NONHUMAN; POROSITY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TISSUE ENGINEERING; TISSUE REGENERATION; X RAY PHOTOELECTRON SPECTROSCOPY;

EID: 66049089260     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2009.02.002     Document Type: Article

References (52)

1. Kubota H., Matsunobu T., Uotani K., Takebe H., Satoh A., and Tanaka T. Production of poly(γ-glutamic acid) by Bacillus subtilis F-2-01. Biosci Biotechnol Biochem 57 (1993) 1212-1213
2. Kubota H., Nambu Y., and Endo T. Convenient and quantitative esterification of poly(γ-glutamic acid) produced by microorganism. J Polym Sci Part A Polym Chem 31 (1993) 2877-2878
3. Shih I.L., and Van Y.T. The production of poly-(γ-glutamic acid) from microorganisms and its various applications. Bioresour Technol 79 (2001) 207-225
4. Otani Y., Tabata Y., and Ikada Y. A new biological glue from gelatin andpoly(γ-glutamic acid). J Biomed Mater Res 31 (1996) 157-166
5. Otani Y., Tabata Y., and Ikada Y. Hemostatic capability of rapidly curable glues from gelatin, poly(γ-glutamic acid), and carbodiimide. Biomaterials 19 (1998) 2091-2098
6. Otani Y., Tabata Y., and Ikada Y. Rapidly curable biological glue composed of gelatin and poly (γ-glutamic acid). Biomaterial 17 (1996) 1387-1391
7. Li C., Ke S., Wu Q.P., Tansey W., Hunter N., Buchmiller L.M., et al. Tumor irradiation enhances the tumor-specific distribution of poly(γ-glutamic acid)-conjugated paclitaxel and its antitumor efficacy. Clin Cancer Res 6 7 (2000) 2829-2834
8. Multani A.S., Li C., Ozen M., Yadav M., Yu D.F., Wallace S., et al. Paclitaxel and water-soluble poly(γ-glutamic acid)-paclitaxel, induce direct chromosomal abnormalities and cell death in a murine metastatic melanoma cell line. Anticancer Res 17 6D (1997) 4269-4274
9. Liang H.F., Chen C.T., Chen S.C., Kulkarni A.R., Chiu Y.L., Chen M.C., et al. Paclitaxel-loaded poly(γ-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Biomaterials 27 (2006) 2051-2059
10. Richard A., and Margaritis A. Poly(glutamic acid) for biomedical applications. Crit Rev Biotechnol 21 4 (2001) 219-232
11. Otani Y., Tabata Y., and Ikada Y. Effect of additives on gelation and tissue adhesion of gelatin-poly(γ-glutamic acid) mixture. Biomaterials 19 (1998) 2167-2173
12. Hsieh C.Y., Tsai S.P., Wang D.M., Chang Y.N., and Hsieh H.J. Preparation of γ-PGA/chitosan composite tissue engineering matrices. Biomaterials 26 (2005) 5617-5623
13. Murakami S., and Aoki N. Bio-based hydrogels prepared by cross-linking of microbial poly(γ-glutamic acid) with various saccharides. Biomacromolecules 7 (2006) 2122-2127
14. Jackson R.I., Busch S.J., and Cardin A.D. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol Rev 71 (1991) 481-539
15. Ayad S., Boot-Handford R.P., Humphries M.J., Kadler K.E., and Shuttleworth C.A. The extracellular matrix-facts book (1994), Academic Press, San Diego
16. Malafaya P.B., Silva G.A., and Reis R.L. Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv Drug Deliver Rev 59 (2007) 207-233
17. Chouzouri G., and Xanthos M. In vitro bioactivity and degradation of polycaprolactone composites containing silicate fillers. Acta Biomaterialia 3 (2007) 745-756
18. Peña J., Corrales T., Izquierdo-Barba I., Serrano M.C., Portolés M.T., Pagani R., et al. Alkaline-treated poly(ε-caprolactone) films: degradation in the presence or absence of fibroblasts. J Biomed Mater Res 76A (2006) 788-797
19. Bei J.Z., Li J.M., Wang Z.F., Le J.C., and Wang S.G. Polycaprolactone-poly(ethylene-glycol)block copolymer. IV: Biodegradationbehavior in vitro and in vivo. Polym Advan Technol 8 11 (1997) 693-696
20. Wiria F.E., Leon K.F., Chua C.K., and Liu Y. Poly-ε-caprolactone/hydroxyapatite for tissue engineering scaffold fabrication via selective laser sintering. Acta Biomaterialia 3 (2007) 1-12
21. Kavlock K.D., Pechar T.W., Hollinger J.O., Guelcher S.A., and Goldstein A.S. Synthesis and characterization of segmented poly(esterurethane urea) elastomers for bone tissue engineering. Acta Biomaterialia 3 (2007) 475-484
22. Xiong X.B., Mahmud A., Uludag H., and Lavasanifar A. Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(ε-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells. Biomacromolecules 8 (2007) 874-884
23. Li W.J., Cooper Jr. J.A., Mauck R.L., and Tuan R.S. Fabrication and characterization of six electrospun poly(α-hydroxy ester)-based fibrous scaffolds for tissue engineering applications. Acta Biomaterialia 2 (2006) 377-385
24. Vaz C.M., Tuijl S., Bouten C.V.C., and Baaijens F.P.T. Design of scaffolds for blood vessel tissue engineering using a multi-layering electrospinning technique. Acta Biomaterialia 1 (2005) 575-582
25. Sarasam A., and Madihally S.V. Characterization of chitosan-polycaprolactone blends for tissue engineering applications. Biomaterials 26 (2005) 5500-5508
26. Wu C.S. A comparison of the structure, thermal properties, and biodegradability of polycaprolactone/chitosan and acrylic acid grafted polycaprolactone/chitosan. Polymer 46 (2005) 147-155
27. Olabarrieta I., ForsstroÈm D., Gedde U.W., and Hedenqvist M.S. Transport properties of chitosan and whey blended with poly(ε-caprolactone) assessed by standard permeability measurements and microcalorimetry. Polymer 42 (2001) 4401-4408
28. Koenig M.F., and Huangt S.J. Biodegradable blends and composites of polycaprolactone and starch derivatives. Polymer 36 9 (1995) 1877-1882
29. Dai N.T., Williamson M.R., Khammo N., Adams E.F., and Coombes A.G.A. Composite cell support membranes based on collagen and polycaprolactone for tissue engineering of skin. Biomaterials 25 (2004) 4263-4271
30. Chong E.J., Phan T.T., Lim I.J., Zhang Y.Z., Bay B.H., Ramakrishna S., et al. Evaluation of electrospun PCL/gelatin nanofibrous scaffold for wound healing and layered dermal reconstitution. Acta Biomaterialia 3 (2007) 321-330
31. Lazzeri L., Cascone M.G., Danti S., Serino L.P., Moscato S., and Bernardini N. Gelatine/PLLA sponge-like scaffolds: morphological and biological characterization. J Mater Sci: Mater Med 17 (2006) 1211-1217
32. Li L., Ding S., and Zhou C. Preparation and degradation of PLA/chitosan. Composite materials. J Appl Polym Sci 91 (2004) 274-277
33. Chen C., Dong L., and Cheung M.K. Preparation and characterization of biodegradable poly(l-lactide)/chitosan blends. Eur Polym J 41 (2005) 958-966
34. Lee C.T., and Lee Y.D. Preparation of porous biodegradable poly (lactide-co- glycolide)/hyaluronic acid blend scaffolds: characterization, in vitro cells culture and degradation behaviors. J Mater Sci: Mater Med 17 (2006) 1411-1420
35. Enobakhare O., Bader D.L., and Lee D.A. Quantification of sulfated glycosaminoglycans in chondrocyte/alginate cultures, by use of 1, 9-dimethylmethylene blue. Anal Biochem 243 (1996) 189-191
36. Pieper J.S., Oosterhof A., Dijkstra P.J., Veerkamp J.H., and van Kuppevelt T.H. Preparation and characterization of porous crosslinked collagenous matrices containing bioavailable chondroitin sulphate. Biomaterials 20 (1999) 847-858
37. Zhang R., and Ma P.X. Poly(a-hydroxyl acids)/hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology. Inc. J Biomed Mater Res 44 (1999) 446-455
38. Ramay H.R., and Zhang M. Preparation of porous hydroxyapatite scaffolds by combination of the gel-casting and polymer sponge methods. Biomaterials 24 (2003) 3293-3302
39. Wu L., and Ding J. In vitro degradation of three-dimensional porous poly(d, l-lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 25 (2004) 5821-5830
40. Lee C.T., Huang C.P., and Lee Y.D. Biomimetic porous scaffolds made from poly(l-lactide)-g-chondroitin sulfate blend with poly(l-lactide) for cartilage tissue engineering. Biomacromolecules 7 (2006) 2200-2209
41. Penkova K., Spirova R., and Bechev R. Modification of Lowry's method for collagen concentration measurement. J Biochem Biophys Methods 32 (1996) 33-43
42. Humphreys T.R., Nemeth A., Mccrevey S., Baer S.C., and Goldberg L.H. Pilot study comparing toluidine blue and hematoxylin and eosin staining of basal cell and squamous cell carcinoma during Mohs surgery. Dermatol Surg 22 (1996) 693-697
43. Ishizeki K., and Nawa T. Further evidence for secretion of matrix metalloproteinase-1 by Meckel's chondrocytes during degradation of the extracellular matrix. Tissue Cell 32 3 (2000) 207-215
44. 13C nuclear magnetic resonance identification and characterization of components of chondroitin sulfates of various origin. Carbohydr Polym 41 (2000) 37-45
45. Mustin C., De Donato P., Benoit R., and Erre R. Spatial distribution of iron and sulphur species on the surface of pyrite. Appl Surf Sci 68 (1993) 147-158
46. Oh S.H., Park I.K., Kim J.M., and Lee J.H. In vitro and in vivo characteristics of PCL scaffolds with pore size gradient fabricated by a centrifugation method. Biomaterials 28 (2007) 1664-1671
47. Kuberka M., von Heimburg D., Schoof H., Heschel I., and Rau G. Magnification of the pore size in biodegradable collagen sponages. Int J Artif Organs 25 (2002) 67-73
48. Kunioka M., and Chio H.J. Hydrolytic degradation and mechanical properties of hydrogels prepared from microbial poly(amino acid)s. Polym Degrad Stabil 59 (1998) 33-37
49. Ingber D., Karpp S., Plopper G., Hansed L., and Mooney D. Physical forces and the mammalian cell vol. 2 (1993), Academic Press, New York
50. Buckwalter J.A., and Mankin H.J. Articular cartilage: tissue design and chondrocyte-matrix interactions. J Bone Joint Surg Am 79A (1997) 600-611
51. Risbud M., Ringe J., Bhonde R., and Sittinger M. In vitro expression of cartilage-specific markers by chondrocytes on a biocompatible hydrogel: Implications for engineering cartilage tissue. Cell Transplant 10 (2001) 755-763
52. von der Mark K., Gauss V., von der Mark H., and Muller P. Relationship between cell shape and type of collagen synthesized as chondrocytes lose their cartilage phenotype in culture. Nature 267 5611 (1977) 531-532